Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study
Bianca Tesi(Karolinska University Hospital), Ann Nordgren(Karolinska University Hospital), Joakim Wille(Skåne University Hospital), Linda Arvidsson, Fulya Taylan(Karolinska University Hospital), Margareta Nordling(Linköping University), Emma Tham(Karolinska University Hospital), G Giraud(St Nicholas Hospital), Katja Ekholm(Karolinska University Hospital), Tony Frisk(Karolinska University Hospital), Richard Rosenquist(Uppsala University), Magnus Sabel(Sahlgrenska University Hospital), David Gisselsson(Heidelberg University), Teresita Díaz de Ståhl(Karolinska University Hospital), Anna Poluha, Ekaterina Kuchinskaya(Linköping University Hospital), Sandra Wessman(Karolinska University Hospital), Gunilla Kanter Smoler(Sahlgrenska University Hospital), Johanna Sandgren(Karolinska University Hospital), Giorgio Tettamanti(Karolinska Institutet), Carolina Maya‐González(Uppsala University), Frida Abel(University of Gothenburg), Magnus Borssén(Umeå University), Per Olof Nyman(Skaraborg Hospital), Gustav Stålhammar(Karolinska Institutet), Ulrika Norén‐Nyström(Umeå University), Susanne Fransson(University of Gothenburg), Gustaf Ljungman(Uppsala University), Fredrik Mertens(Lund University), Sofie Samuelsson, Kristina Lagerstedt‐Robinson(Karolinska University Hospital), Maria Filì(Karolinska Institutet), Maria Hellberg, Cornelis Jan Pronk(Lund University), Per Kogner(Karolinska University Hospital), Päivi M. Lähteenmäki(Karolinska Institutet), Anna‐Lotta Hallbeck(Linköping University), Tommy Martinsson(University of Gothenburg), Torben Ek(Sahlgrenska University Hospital), Hartmut Vogt(Linköping University), Niklas Pal(Karolinska University Hospital), Pernilla Grillner(Karolinska University Hospital), Sara Orrsjö(Sahlgrenska University Hospital), Pia Palmebäck(Linköping University Hospital), Alia Shamik(Karolinska University Hospital), Valtteri Wirta(Karolinska University Hospital), Nikolas Herold(Karolinska University Hospital), Karin Henning(Karolinska University Hospital), Anna Rosén(Umeå University)
Cited by 19
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
|Arthritis & Rheumatism|2006|888
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795